Examining the financial impact that patient assistance programs and the 340B Drug Pricing Program have on improving medication cost.
We estimated the long-term risks and benefits of disease modifying therapies. Benefits were favored by natalizumab with minimal increased risks in the negative anti-JC virus population.
Findings of this qualitative interview study suggest promise, but also challenges, with regard to using preventive drug lists to help families manage asthma medication costs.
A patient-centered medical home with intensive case management and a payer partner can significantly improve hospital utilization and may decrease total medical costs for a Medicare population.
The upward trend in total and outpatient healthcare expenditures in the United States appears to be unrelated to psychological distress.
In the midst of the coronavirus disease 2019 (COVID-19) pandemic, health care leaders must work to optimize emergency department and hospital efficiency while maintaining patient access to care.
The combination of electronic consultations and active triage of specialty care consults effectively reduces wait times for outpatient clinics.
The authors evaluate methods for implementing clinical research and guidelines, in order to change physician practice patterns, in surgical and general practice.
Although the fundamental structure of Medicare Part D remained the same in 2010, the beneficiary provisions continued to improve.
Standardized measurement of migraine, an underdiagnosed and perhaps underrecognized condition, is necessary for health plans to understand utilization of costly diagnostic and treatment services.
Greater consumer participation in determining how HIE occurs could engender greater trust among all demographic groups, regardless of varying levels of privacy and security concerns.
Lee N. Newcomer, MD, MHA, joined the response panel, Challenges and Opportunities for Quality Measures in Oncology.
Breast cancer screening may not improve in early medical home implementation.
A dive into the Quality Payment Program and other healthcare reform models introduced in cancer care that healthcare providers are adjusting to as we move toward value-based care.
Artificial intelligence based on medical claims data outperforms traditional models in stratifying patient risk.
When controlling for maternal and hospital factors, cesarean delivery rates increased more rapidly for privately versus publicly funded births, with important cost and health implications.
Many more patient than provider characteristics are associated with optimal or poor glycemic control and treatment intensification when glycemic control is initially lost.